SHS acquires puracon
One of the funds consulted by the Tübingen based company, SHS Gesellschaft für [...]
Golding Capital Partners wins another management mandate for infrastructure investments
Golding Capital Partners (GCP) now manages a €175 million mandate for infrastructure investments [...]
SHS acquires majority share in SIS-SCHWAGER Group
With its fourth fund, the medical technology investor SHS Gesellschaft für Beteiligungsmanagement from [...]
Kidney rejection after transplantation: numares develops radically new urinalysis procedure
As part of its UMBRELLA study, numares HEALTH has discovered a urinalysis procedure [...]
TNI medical: more capital for innovative respiratory disease treatment
The SHS portfolio company TNI medical is receiving further funding in a second [...]
numares expands range of lipid analysis products
Regensburg-based company numares has developed a new test system for use in diagnostic [...]
SHS acquires Novo Klinik-Service GmbH
With its fourth fund, the Tübingen based medical technology investor SHS Gesellschaft für [...]
SHS invests in molecular diagnostics specialist GNA Biosolutions
The fund SHS IV has invested in GNA Biosolutions GmbH together with existing [...]
numares technology offers performance and robustness: 500,000 lipoprotein tests in US laboratory
The U.S. based laboratory HEALTH DIAGNOSTIC LABORATORY, Inc. (HDL, Inc.) has performed 500,000 [...]
numares announces lipoFIT-S100 market launch
World's first CE-labeled NMR-based in-vitro diagnostic system - This enables diagnostic and research [...]